Krystal Biotech Non-Current Deferred Revenue (Quarterly) Analysis

Krystal Biotech, Inc. (KRYS)

272.43 +11.02 (+4.22%) USD | NASDAQ | Jan 12, 16:00

272.00 -0.43 (-0.16%) After-Hours: 19:53

View Non-Current Deferred Revenue (Quarterly) for KRYS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

DexCom, Inc.	--
BioLife Solutions, Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Catalyst Pharmaceuticals, Inc.	--
Amicus Therapeutics, Inc.	--